The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
10 2023
Historique:
received: 20 06 2023
revised: 06 07 2023
accepted: 10 07 2023
medline: 29 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

In 2014, a TNM-based system for thymic epithelial tumors was proposed. The TNM stage classification system was published as a result of a joint project from the International Association for the Study of Lung Cancer and the International Thymic Malignancy Interest Group for the eighth edition of the American Joint Commission on Cancer and the Union for International Cancer Control stage classification system. The Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer received the mandate to make proposals for the ninth edition of the TNM stage classification. A central thymic database was collected by the Cancer Research And Biostatistics with the contribution of the major thymic associations in the world. A total of 11,347 patients were collected. Submitting organizations were the following: Japanese Association for Research in the Thymus, European Society of Thoracic Surgeons, Chinese Alliance for Research in Thymoma, Korean Association for Research in the Thymus, International Thymic Malignancy Interest Group, and Réseau tumeurs THYMiques et Cancer. Additional contributions came from centers in the United States, United Kingdom, Turkey, Australia, Spain, and Italy. A total of 9147 cases were eligible for analysis. Eligible cases for analysis came from Asia and Australia (5628 cases, 61.5%), Europe (3113 cases, 34.0%), and North America (406 cases, 4.4%). This report provides an overview of the database that has informed the proposals for the updated T, N, and M components and the stage groups for the ninth TNM of malignant tumors.

Identifiants

pubmed: 37702630
pii: S1556-0864(23)00672-X
doi: 10.1016/j.jtho.2023.07.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1386-1398

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Andreas Rimner (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Enrico Ruffini (E)

University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it.

Vanessa Cilento (V)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Emily Goren (E)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Usman Ahmad (U)

Thoracic Surgery in the Heart, Vascular & Thoracic Institute at Cleveland Clinic, Abu Dhabi, United Arab Emirates.

Sarit Appel (S)

Sheba Medical Center, Ramat Gan, Israel.

Andrea Bille (A)

Guy's Hospital, London, United Kingdom.

Souheil Boubia (S)

University Hospital Ibn Rochd, Casablanca, Morocco.

Cecilia Brambilla (C)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Ayten Kayi Cangir (AK)

Ankara University Faculty of Medicine, Ankara, Turkey.

Frank Detterbeck (F)

Yale University School of Medicine, New Haven, Connecticut.

Conrad Falkson (C)

Queen's University in Kingston, Ontario, Canada.

Wentao Fang (W)

Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.

Pier Luigi Filosso (PL)

Baggiovara Civil Hospital, University of Modena, Modena, Italy.

Giuseppe Giaccone (G)

Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.

Nicolas Girard (N)

Institut Curie, Thorax Institute Curie Montsouris, Paris, France; Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Paris Saclay University, Versailles, France.

Francesco Guerrera (F)

University of Torino, Torino, Italy.

James Huang (J)

Memorial Sloan Kettering Cancer Center, New York, New York.

Maurizio Infante (M)

University and Hospital Trust, Verona, Italy.

Dong Kwan Kim (DK)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Marco Lucchi (M)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Mirella Marino (M)

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.

Edith M Marom (EM)

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.

Andrew G Nicholson (AG)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Meinoshin Okumura (M)

National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.

Ramon Rami-Porta (R)

Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

Charles B Simone (CB)

Memorial Sloan Kettering Cancer Center, New York, New York.

Hisao Asamura (H)

Keio University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH